TIAA CREF Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$19.4M Buy
38,558
+12,605
+49% +$6.35M 0.01% 719
2018
Q4
$12.8M Sell
25,953
-2,703
-9% -$1.33M 0.01% 836
2018
Q3
$26.2M Buy
28,656
+869
+3% +$795K 0.02% 631
2018
Q2
$20.4M Sell
27,787
-15,173
-35% -$11.1M 0.01% 738
2018
Q1
$68.5M Buy
42,960
+1,260
+3% +$2.01M 0.05% 367
2017
Q4
$37.4M Buy
41,700
+4,767
+13% +$4.27M 0.02% 534
2017
Q3
$13.3M Sell
36,933
-1,408
-4% -$507K 0.01% 978
2017
Q2
$11.2M Sell
38,341
-10,667
-22% -$3.13M 0.01% 1061
2017
Q1
$17.3M Buy
49,008
+8,984
+22% +$3.16M 0.01% 814
2016
Q4
$7.37M Buy
40,024
+2,557
+7% +$471K 0.01% 1329
2016
Q3
$9.66K Sell
37,467
-592
-2% -$153 0.01% 1141
2016
Q2
$8.12M Sell
38,059
-1,396
-4% -$298K 0.01% 1193
2016
Q1
$8.14M Sell
39,455
-601
-2% -$124K 0.01% 1176
2015
Q4
$10.1M Sell
40,056
-621
-2% -$157K 0.01% 1062
2015
Q3
$6.69M Sell
40,677
-1,392
-3% -$229K 0.01% 1334
2015
Q2
$7.89M Sell
42,069
-6,206
-13% -$1.16M 0.01% 1331
2015
Q1
$7.97M Sell
48,275
-309
-0.6% -$51K 0.01% 1304
2014
Q4
$11.3M Sell
48,584
-1,634
-3% -$380K 0.01% 1037
2014
Q3
$9.09M Sell
50,218
-885
-2% -$160K 0.01% 1155
2014
Q2
$9.83M Buy
51,103
+1,575
+3% +$303K 0.01% 1173
2014
Q1
$9M Buy
49,528
+997
+2% +$181K 0.01% 1205
2013
Q4
$8.26M Sell
48,531
-229
-0.5% -$39K 0.01% 1275
2013
Q3
$7.64M Sell
48,760
-651
-1% -$102K 0.01% 1265
2013
Q2
$8.56M Buy
+49,411
New +$8.56M 0.01% 1145